Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study

NCT07620574 is registered in ClinicalTrials.gov with Exelixis as lead sponsor.

NCT NCT07620574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07620574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
Lead sponsor
Exelixis
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
July 30, 2026
Completion date
May 31, 2030
Enrollment
5,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, colorectal cancer, differentiated thyroid cancer (dtc), extra-pancreatic net (epnet), hepatocellular carcinoma (hcc), non-clear cell renal cell carcinoma (nccrcc), pancreatic neuroendocrine tumors (pnet), prostate cancer, renal cell carcinoma (rcc)